Facing increased competition in the weight loss market and intense pressure from President Donald Trump, Novo Nordisk ...
Signs of a weight loss price war appeared to worry investors early Monday, and Lilly and Novo stocks were down.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback